| Titre : | Initiation of buprenorphine during incarceration and retention in treatment upon release (2013) |
| Auteurs : | N. ZALLER ; M. McKENZIE ; P. D. FRIEDMANN ; T. C. GREEN ; S. McGOWAN ; J. D. RICH |
| Type de document : | Article : Périodique |
| Dans : | Journal of Substance Abuse Treatment (Vol.45, n°2, August 2013) |
| Article en page(s) : | 222-226 |
| Langues: | Anglais |
| Discipline : | TRA (Traitement et prise en charge / Treatment and care) |
| Mots-clés : |
Thésaurus géographique ETATS-UNISThésaurus mots-clés PRISON ; TRAITEMENT DE MAINTENANCE ; BUPRENORPHINE ; INCARCERATION ; PRISE EN CHARGE ; NALOXONE ; INITIATION |
| Résumé : | We report here on a feasibility study of initiating buprenorphine/naloxone prior to release from incarceration and linking participants to community treatment providers upon release. The study consisted of a small number of Rhode Island (RI) prisoners (N = 44) diagnosed with opioid dependence. The study design is a single arm, open-label pilot study with a 6-month follow up interview conducted in the community. However, a natural experiment arose during the study comparing pre-release initiation of buprenorphone/naloxone to initiation post-release. Time to post-release prescriber appointment (mean days) for initiation of treatment outside Rhode Island Department of Corrections (RIDOC) versus inside RIDOC was 8.8 and 3.9, respectively (p = .1). Median post release treatment duration (weeks) for outside RIDOC versus inside RIDOC was 9 and 24, respectively (p = .007). We conclude that initiating buprenorphine/naloxone prior to release from incarceration may increase engagement and retention in community-based treatment. |
| Domaine : | Drogues illicites / Illicit drugs |
| Affiliation : | The Miriam Hospital, Providence, RI, USA |
Accueil
